The genotoxicity of fluoride in vivo in seven patients with osteoporosis wa
s cytogenetically investigated. The patients were treated with fluoride-con
taining formulations (disodium monofluorophosphate and sodium fluoride) for
a period of 15 months up to 49 months. Fluoride intake ranged from 22.6-33
.9 mg F/day and serum fluoride concentrations were between 0.1 mg F/l and 0
.2 mg F/. Peripheral blood lymphocytes of these patients were cultured in v
itro and examined for chromosomal aberrations, micronuclei in cytokinesis-b
locked binucleated lymphocytes as well as cell cycle progression. When a co
mparison was made between patients' group and a matched control group, it w
as found that fluoride at the tested concentrations had no detectable genot
oxic potential in human lymphocytes in vivo.